Lv2
130 积分 2024-02-17 加入
Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
14天前
已完结
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
14天前
已完结
Short-term Prostate-specific Antigen Pseudoregression Following [177Lu]–Prostate-specific Membrane Antigen Therapy
14天前
已完结
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
22天前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
22天前
已完结
Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
1个月前
已完结
177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
The Efficacy and Safety of Hyperthermia Intravesical Chemotherapy in the Treatment of Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis
1个月前
已完结
腹腔镜下腹股沟淋巴结清扫术后即刻灌注铜绿假单胞菌注射液预防淋巴漏的对比研究
4个月前
已完结
腹腔镜与开放性腹股沟淋巴结清扫术的临床比较及分析
4个月前
已完结
皖公网安备34019202002308
